Skip to main content

Table 1 Patient characteristics (n = 253)

From: Correction to: Preliminary result of carbon-ion radiotherapy using the spot scanning method for prostate cancer

Characteristics n (%)
Follow-up duration, months, median (range) 35.3 (4.1–52.9)
Age, years, median (range) 70 (47–86)
T stage  
 1c 49 (19.4%)
 2a 79 (31.2%)
 2b 35 (13.8%)
 2c 53 (20.9%)
 3a 27 (10.7%)
 3b 10 (4.0%)
Pretreatment PSA, ng/ml, median (range) 8.6 (3.33–187)
 < 10 147 (58.1%)
 10 ≤ 20 73 (28.9%)
 20 ≤ 33 (13.0%)
Gleason score  
 6 14 (5.5%)
 7 117 (46.2%)
 8 79 (31.2%)
 9 43 (17.0%)
 10 0 (0.0%)
D’Amico classification  
 low 8 (3.2%)
 intermediate 88 (34.8%)
 high 157 (62.1%)
ADT  
 none 9 (3.6%)
 neoadjuvant 87 (34.4%)
 neoadjuvant and adjuvant 157 (62.1%)
Complications, histories  
 Diabetes mellitus 25 (9.9%)
 Internal use of anticoagulants 41 (16.2%)
 Benign prostate hyperplasia 18 (7.1%)
 TURP 4 (1.6%)
  1. PSA prostate specific antigen, ADT androgen deprivation therapy, TURP transurethral resection of the prostate